Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
INVESTOR REMINDER: Berger Montague Notifies Novo Nordisk A/S (NYSE: NVO) Investors of a Class Action Lawsuit and Deadline
01:36pm, Monday, 18'th Aug 2025
PHILADELPHIA , Aug. 18, 2025 /PRNewswire/ -- Berger Montague PC is investigating claims under the federal securities laws against Novo Nordisk A/S (NYSE: NVO) ("Novo" or the "Company"), a global
Novo Nordisk's Loss Is Eli Lilly's Gain, And Vice Versa
01:27pm, Monday, 18'th Aug 2025
Novo Nordisk A/S's FDA approval for Wegovy in MASH and aggressive Ozempic pricing boost its position, despite recent stock declines and competitive pressure from Eli Lilly and Company. Both NVO and LL
Novo Nordisk to sell weight-loss drug for $499 to eligible customers
01:15pm, Monday, 18'th Aug 2025
Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through multiple pharmacy platforms.
Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk's breakup with Hims
01:11pm, Monday, 18'th Aug 2025
Share prices of GoodRx (NASDAQ: GDRX), the American healthcare company and telemedicine service, are currently soaring after the company announced that it will partner with Novo Nordisk to offer the l
NVO Stock Up on FDA Nod for Wegovy in MASH: More Upside Ahead?
12:46pm, Monday, 18'th Aug 2025
Novo Nordisk surges as Wegovy secures FDA approval for MASH, marking a breakthrough in liver care and expanding its blockbuster reach.
Top Stock Movers Now: Dayforce, Novo Nordisk, First Solar, and More
12:30pm, Monday, 18'th Aug 2025
Major U.S. equities indexes were little changed Monday morning, ahead of retail sector earnings reports and comments from Federal Reserve Chair Jerome Powell due later in the week.
Novo Nordisk A/S (NVO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
12:00pm, Monday, 18'th Aug 2025
LOS ANGELES , Aug. 18, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Novo Nordisk A/S ("Novo Nordisk" or the "Company") (NYSE: NVO) have opport
Novo Nordisk Surges On Wegovy Win, Eyes Bullish Rebound Near 52-Week Lows
11:53am, Monday, 18'th Aug 2025
Novo Nordisk A/S NVO may have found a timely catalyst. From the lows of its 52-week trading range, the Danish drugmaker is showing signs that a bullish comeback might be on the horizon—driven by bot
Novo Nordisk's Wegovy receives FDA approval to treat serious liver disease
11:29am, Monday, 18'th Aug 2025
CNBC's Angelica Peebles joins 'Squawk on the Street' to discuss the latest news on Novo Nordisk, what new FDA approval on its Wegovy drug means for sales, and much more.
Novo Nordisk expands access to Ozempic, Wegovy through GoodRx and other platforms
11:26am, Monday, 18'th Aug 2025
Novo Nordisk (NYSE:NVO) shares moved higher on Monday after it was announced that US patients can access its diabetes drug Ozempic at a cheaper price through several platforms, expanding access to th
Why Novo Nordisk Stock Popped Monday
10:32am, Monday, 18'th Aug 2025
Shares of Novo Nordisk (NVO 4.68%), the Danish pharmaceuticals company famed for Ozempic and Wegovy weight loss drugs, jumped 5% through 9:55 a.m. ET Monday on a series of positive announcements for i
NVDA Price Target Hikes, NVO Gains on Wegovy FDA Approval, DAY Up Over 25%
10:30am, Monday, 18'th Aug 2025
Novo Nordisk (NVO) jumped higher after the FDA approved the company's Wegovy drug as a liver disease treatment. Dayforce (DAY) rallied more than 25% off reports that Thoma Bravo is looking to acquire
Novo Cuts Price of Ozempic in Half for Cash Buyers
10:29am, Monday, 18'th Aug 2025
Novo Nordisk A/S is slashing the cost of Ozempic for cash-paying patients to $499 a month through NovoCare and partnering with GoodRx Holdings Inc. to offer it at the same price at US pharmacies. Bloo
Novo Nordisk to sell Ozempic directly
09:55am, Monday, 18'th Aug 2025
CNBC's Angelica Peebles joins 'Squawk on the Street' with the latest news on Novo Nordisk.
GoodRx Stock Spikes 35% on Novo Nordisk Collaboration. They're Offering Ozempic for $499 a Month.
09:53am, Monday, 18'th Aug 2025
GoodRx announces a collaboration with Novo Nordisk to make Ozempic cheaper for self-paying patients.
